Thanks
Several recent studies conducted in children and young people show that Humira (also known as adalimumab) is effective in the treatment of Crohn disease.
This drug is given as a subcutaneous injection (under the skin) every 2 weeks. Different countries have different access to this drug.
Humira has similar side-effects to Infliximab, but does have much lower rates of reactions following each dose compared to Infliximab. Infliximab and adalimumab work on the same parts of the inflammatory processes.
You must be a HealthShare member to report this post.
to your account or now (it's free).